INDSWFTLAB

Ind-Swift Laboratories Limited

Pharmaceuticals

Share price

₹400

Market cap

₹3,478 Cr

1Y return

▲ 294%

A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.

Investors holding Ind-Swift Laboratories Limited

NG

Foreign Investor

2.96%

Recent moves 4

Essix Biosciences Limited

17 Sept 2026. Sign in to see this move

Nova GlobalNew position

Nova Global entered Ind-Swift Laboratories with 25,72,991 shares, a 2.96% stake, valued at approximately ₹59.63 Cr.

Nova GlobalNew position

Nova Global bought 803,387 shares of Ind-Swift Laboratories for ₹11.09 Cr at ₹138.07 apiece in a bulk deal.

Sahastraa AdvisorsNew position

Sahastraa Advisors bought 4,75,000 shares of Ind-Swift Laboratories for ₹6.26 Cr at ₹131.74 apiece in a bulk deal on April 17, 2026.

Track the whales in Ind-Swift Laboratories Limited

Get alerted the moment a top investor buys or sells.